BeOne Medicines Ltd.
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines Amgen Collaboration by Year
Amgen Collaboration — Total R&D Financing Commitment Expense ($M) ($M)
BeOne Medicines Amgen Collaboration: $205M in FY2025, up 38.3% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-Q / 10-K Collaborative Arrangements Note (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Amgen Collaboration — Total R&D Financing Commitment Expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 205 | +38.3% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 148 | +36.6% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 109 | -44.4% | Form 10-K (filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 195 | -14.3% | Form 10-K (filed 2025-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 228 | -1.3% | Form 10-K (filed 2024-02-26) ↗ |
| FY2020 | Dec 31, 2020 | 231 | – | Form 10-K (filed 2023-02-27) ↗ |
Breakdown
What makes up amgen Collaboration
Cite this data
StockData. (2026). BeOne Medicines Amgen Collaboration ($M), annual FY2020–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/amgen-fin-commit-exp
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.